The development aligns with recent guidance from the WHO concerning tuberculosis molecular diagnostics in India.

Co-Diagnostics Inc. CODX on Wednesday announced that it has commenced shipments of PCR Pro instruments, Co-Dx PCR MTB test ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...

Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution SALT LAKE CITY, Feb. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the U.S. launch of the latest addition to the company's real-time PCR portfolio of LightCycler® instruments for use in research, the LightCycler Nano ...

Designed with a scalable architecture, the QuantStudio™ 3D Digital PCR System's first generation chips enable up to 20,000 data points in a single run — coverage that satisfies the needs for most ...

FOSTER CITY, Calif. & HAMBURG, Germany--(BUSINESS WIRE)--Nov. 11, 2005--Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced it has granted a worldwide, ...

The global molecular diagnostics market is projected to reach $31.8 billion by 2026, up from $17.8 billion in 2021, with the polymerase chain reaction (PCR) segment accounting for the largest share, ...

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution Mohal Sarabhai, CEO of CoSara, remarked, "We believe this landmark ...